Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours
Journal of Neuro-Oncology · 2024-09 · 169 (2) · 233-239
DOI: 10.1007/s11060-024-04695-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 05.08.2024. Verfasst von A P Landry und 10 weiteren Autor:innen. Beteiligte Einrichtung: MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, DNA Methylation, Proteome, Biomarkers, Tumor. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Liquid biopsy represents a major development in cancer research, with significant translational potential. Similarly, it is increasingly recognized that multi-omic molecular approaches are a powerful avenue through which to understand complex and heterogeneous disease biology. We hypothesize that merging these two promising frontiers of cancer research will improve the discriminatory capacity of current models and allow for improved clinical utility. METHODS: We have compiled a cohort of patients with glioblastoma, brain metastasis, and primary central nervous system lymphoma. Cell-free methylated DNA immunoprecipitation (cfMeDIP) and shotgun proteomic profiling was obtained from the cerebrospinal fluid (CSF) of each patient and used to build tumour-specific classifiers. RESULTS: We show that the DNA methylation and protein profiles of cerebrospinal fluid can be integrated to fully discriminate lymphoma from its diagnostic counterparts with perfect AUC of 1 (95% confidence interval 1-1) and 100% specificity, significantly outperforming single-platform classifiers. CONCLUSIONS: We present the most specific and accurate CNS lymphoma classifier to date and demonstrates the synergistic capability of multi-platform liquid biopsies. This has far-reaching translational utility for patients with newly diagnosed intra-axial brain tumours.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada.
- Division of Neurosurgery, Department of Surgery, University of Toronto, 399 Bathurst Street, West Wing 4-427, Toronto, ON, M5T 2S8, Canada.
- Department of Medical Biophysics, University of Toronto, Toronto, Canada.
- MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. farshad.nassiri@mail.utoronto.ca.
- Division of Neurosurgery, Department of Surgery, University of Toronto, 399 Bathurst Street, West Wing 4-427, Toronto, ON, M5T 2S8, Canada. farshad.nassiri@mail.utoronto.ca.
- MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. gelareh.zadeh@uhn.ca.
Förderung
- NCI NIH HHS
Zitieren
APA
Landry, A. P., Zuccato, J. A., Patil, V., Voisin, M. R., Wang, J. Z., Ellenbogen, Y., Gui, C., Ajisebutu, A., Kislinger, T., Nassiri, F., & Zadeh, G. (2024). Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours. Journal of Neuro-Oncology, 169(2), 233-239. https://doi.org/10.1007/s11060-024-04695-2
Vancouver
Landry AP, Zuccato JA, Patil V, Voisin MR, Wang JZ, Ellenbogen Y, et al. Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours. Journal of Neuro-Oncology. 2024;169(2):233-239. doi:10.1007/s11060-024-04695-2
BibTeX
@article{Landry2024,
author = {Landry, A P and Zuccato, J A and Patil, V and Voisin, M R and Wang, J Z and Ellenbogen, Y and Gui, C and Ajisebutu, A and Kislinger, T and Nassiri, F and Zadeh, G},
title = {Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours},
journal = {Journal of Neuro-Oncology},
year = {2024},
volume = {169},
number = {2},
pages = {233--239},
doi = {10.1007/s11060-024-04695-2}
}
EUVIMED